Earningsreport

Q2/2019 6/30/2019 EPS -0.230 ZacksConsensus -0.170 ActVsEst (0.060) - Miss

TherapeuticsMD, Inc.  (TXMD) 
NASDAQ:AMEX Investor Relations: ir.therapeuticsmd.com